Avantor, Inc. (AVTR)
15.47
+0.33
(+2.18%)
USD |
NYSE |
Nov 06, 16:00
15.40
-0.07
(-0.45%)
Pre-Market: 20:00
Avantor Total Long Term Debt (Quarterly) : 3.684B for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.684B |
| June 30, 2026 | 3.698B |
| March 31, 2026 | 3.816B |
| December 31, 2025 | 4.098B |
| September 30, 2025 | 3.858B |
| June 30, 2025 | 4.242B |
| March 31, 2025 | 4.107B |
| December 31, 2024 | 4.199B |
| September 30, 2024 | 4.921B |
| June 30, 2024 | 5.115B |
| March 31, 2024 | 5.323B |
| December 31, 2023 | 5.625B |
| September 30, 2023 | 5.626B |
| June 30, 2023 | 5.884B |
| March 31, 2023 | 6.061B |
| December 31, 2022 | 6.374B |
| September 30, 2022 | 6.188B |
| June 30, 2022 | 6.539B |
| Date | Value |
|---|---|
| March 31, 2022 | 6.860B |
| December 31, 2021 | 7.102B |
| September 30, 2021 | 5.587B |
| June 30, 2021 | 5.651B |
| March 31, 2021 | 4.633B |
| December 31, 2020 | 4.992B |
| September 30, 2020 | 5.071B |
| June 30, 2020 | 5.078B |
| March 31, 2020 | 5.055B |
| December 31, 2019 | 5.223B |
| September 30, 2019 | 5.227B |
| June 30, 2019 | 5.429B |
| March 31, 2019 | 6.793B |
| December 31, 2018 | 6.925B |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 7.118B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Champions Oncology, Inc. | 10.34M |
| Medpace Holdings, Inc. | 146.04M |
| Personalis, Inc. | 30.21M |
| Adaptive Biotechnologies Corp. | 399.83M |
| 10X Genomics, Inc. | 63.85M |